What Should You Do With Your AstraZeneca plc Shares?

As Pfizer continues its attempts for a takeover of AstraZeneca (LSE: AZN) (NYSE: AZN.US), Motley Fool managing director Jill Ralph and senior analyst Nate Weisshaar discuss what might be best for shareholders in the British pharmaceutical firm…

If you own shares in AstraZeneca and are looking for other high-yielders outside the sector, then check out this free wealth report from The Motley Fool, which identifies five names that should provide you with a comfortable, stress-free retirement. Just click here for details, with no obligations!

Neither Nate nor Jill own shares in AstraZeneca.